MHC and TAP-1 Expression in Cervical Cancer Metastases
Author Information
Author(s): F.V. Crommel, P.F.J. van Bommel, J.M.M. Walboomers, M.P.W. Gallee, P.L. Stern, P. Kenemans, Th.J.M. Helmerhorst, M.J. Stukart, C.J.L.M. Meijer
Primary Institution: Free University Hospital, Amsterdam, The Netherlands
Hypothesis
Loss of TAP-1 and the consequent down-regulation of class I MHC expression provides a selective advantage for neoplastic cervical cells during metastasis.
Conclusion
The study found that cervical cancer metastases show a significant increase in the down-regulation of class I MHC compared to primary tumors.
Supporting Evidence
- Down-regulation of class I MHC expression was found in a significant proportion of primary cervical carcinomas.
- Class II MHC expression was frequently up-regulated in primary tumors but absent in metastases.
- Loss of TAP-1 expression was consistently associated with down-regulation of class I MHC.
Takeaway
This study looked at how certain proteins in cervical cancer cells change when they spread to other parts of the body, finding that some proteins are less present in the spread-out cancer cells.
Methodology
The study analyzed MHC and TAP-1 expression in primary cervical tumors and lymph node metastases using immunohistochemistry.
Participant Demographics
Patients with cervical carcinoma stage IB or IIA treated at the Free University Hospital in Amsterdam.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website